{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:32:30Z","timestamp":1785227550685,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.medmal.2018.11.003","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T10:46:23Z","timestamp":1543920383000},"page":"275-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Thesaurus for off-label indications for systemic antifungal agents"],"prefix":"10.1016","volume":"49","author":[{"given":"A.L.","family":"Bienvenu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aussedat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kavafian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Paillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Juillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chidiac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Leboucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2018.11.003_bib0110","series-title":"Loi no\u00a02003-1199 du 18 d\u00e9cembre 2003 de financement de la s\u00e9curit\u00e9 sociale pour 2004","year":"2004"},{"key":"10.1016\/j.medmal.2018.11.003_bib0115","series-title":"D\u00e9cret no\u00a02016-349 du 24 mars 2016 relatif \u00e0 la proc\u00e9dure et aux conditions d\u2019inscription des sp\u00e9cialit\u00e9s pharmaceutiques sur la liste mentionn\u00e9e \u00e0 l\u2019article L.\u00a0162-22-7 du Code de la s\u00e9curit\u00e9 sociale","year":"2016"},{"key":"10.1016\/j.medmal.2018.11.003_bib0120","series-title":"D\u00e9cret no\u00a02005-1023 du 24 ao\u00fbt 2005 relatif au Contrat de Bon Usage des m\u00e9dicaments et des produits et prestations mentionn\u00e9 \u00e0 l\u2019article L.\u00a0162-22-7 du Code de la s\u00e9curit\u00e9 sociale","year":"2005"},{"key":"10.1016\/j.medmal.2018.11.003_bib0125","series-title":"D\u00e9cret no\u00a02012-742 du 9 mai 2012 relatif aux recommandations temporaires d\u2019utilisation des sp\u00e9cialit\u00e9s pharmaceutiques","year":"2012"},{"key":"10.1016\/j.medmal.2018.11.003_bib0130","series-title":"D\u00e9cret no\u00a02017-584 du 20 avril 2017 fixant les modalit\u00e9s d\u2019application du contrat d\u2019am\u00e9lioration de la qualit\u00e9 et de l\u2019efficience des soins","year":"2017"},{"key":"10.1016\/j.medmal.2018.11.003_bib0135","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3111\/13696998.2014.1000460","article-title":"An update to the cost-effectiveness of posaconazole vs fluconazole or itraconazole in the prevention of invasive fungal disease among neutropenic patients in the United States","volume":"18","author":"Sung","year":"2015","journal-title":"J Med Econ"},{"key":"10.1016\/j.medmal.2018.11.003_bib0140","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10096-015-2340-y","article-title":"Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia","volume":"34","author":"D\u00f6ring","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2018.11.003_bib0145","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1128\/AAC.03050-14","article-title":"Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia","volume":"58","author":"Duarte","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2018.11.003_bib0150","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"Suppl.\u00a07","key":"10.1016\/j.medmal.2018.11.003_bib0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medmal.2018.11.003_bib0160","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.11.003_bib0165","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/lt.24419","article-title":"Echinocandins for antifungal prophylaxis in liver transplant recipients: advance in the field or variation on a theme?","volume":"22","author":"Koval","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.medmal.2018.11.003_bib0170","doi-asserted-by":"crossref","first-page":"564","DOI":"10.5414\/CP202255","article-title":"Safety and effectiveness of antifungal prophylaxis in preventing fungal infection after liver transplantation: a meta-analysis of randomized clinical trials","volume":"54","author":"Xing","year":"2016","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.medmal.2018.11.003_bib0175","doi-asserted-by":"crossref","first-page":"6212503","DOI":"10.1155\/2016\/6212503","article-title":"Effect of prophylactic antifungal protocols on the prognosis of liver transplantation: a propensity score matching and multistate model approach","volume":"2016","author":"Chen","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.medmal.2018.11.003_bib0180","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1016\/j.ijid.2011.01.011","article-title":"Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study","volume":"15","author":"Tan","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.medmal.2018.11.003_bib0185","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/597395","article-title":"Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.11.003_bib0190","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.11.003_bib0195","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s00134-013-3109-3","article-title":"A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts","volume":"39","author":"Bassetti","year":"2013","journal-title":"Intensive Care Med"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.medmal.2018.11.003_bib0200","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1469-0691.12360","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections","volume":"20","author":"Arendrup","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.medmal.2018.11.003_bib0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/1469-0691.12515","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi","volume":"20","author":"Chowdhary","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.medmal.2018.11.003_bib0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1469-0691.12465","article-title":"ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others","volume":"20","author":"Tortorano","year":"2014","journal-title":"Clin Microbiol Infect"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X18305808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X18305808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:17:05Z","timestamp":1759972625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X18305808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0399077X18305808"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2018.11.003","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thesaurus for off-label indications for systemic antifungal agents","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2018.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}